相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index
Yucai Wang et al.
BLOOD CANCER JOURNAL (2021)
Cause-specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinaemia, 2000-2016
Nicole H. Dalal et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Early progression of disease predicts shorter survival in patients with mucosa-associated lymphoid tissue lymphoma receiving systemic treatment
Annarita Conconi et al.
HAEMATOLOGICA (2020)
Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype
Hasan Abuamsha et al.
HEMATOLOGICAL ONCOLOGY (2019)
Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study
Stefano Luminari et al.
BLOOD (2019)
Revised-MALT-IPI: A New Predictive Model That Identifies High-Risk Patients with Extranodal Marginal Zone Lymphoma (EMZL)
Juan Pablo Alderuccio et al.
BLOOD (2019)
Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes
Laura L. Hester et al.
CANCER (2019)
Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts
Clementine Sarkozy et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomas
Sean I. Tracy et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations
V Pillonel et al.
LEUKEMIA (2018)
The association of physical activity before and after lymphoma diagnosis with survival outcomes
Priyanka A. Pophali et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study
James R. Cerhan et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)
Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort study
Paolo Strati et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Transformation of marginal zone lymphoma (and association with other lymphomas)
Carla Casulo et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2017)
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma
Matthew J. Maurer et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Optimizing therapy for nodal marginal zone lymphoma
Catherine Thieblemont et al.
BLOOD (2016)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era
Adam G. Starr et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402
Michael E. Williams et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
2016 US Lymphoid Malignancy Statistics by World Health Organization Subtypes
Lauren R. Teras et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project
Anamarija M. Perry et al.
HAEMATOLOGICA (2016)
Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project
Anamarija M. Perry et al.
HAEMATOLOGICA (2016)
Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011
Mohammed Al-Hamadani et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network
A. Smith et al.
BRITISH JOURNAL OF CANCER (2015)
Competing risk survival analysis in patients with symptomatic Waldenstrom macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy
Efstathios Kastritis et al.
HAEMATOLOGICA (2015)
Competing risk survival analysis in patients with symptomatic Waldenstrom macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy
Efstathios Kastritis et al.
HAEMATOLOGICA (2015)
Overall survival and competing risks of death in patients with Waldenstrom macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database
Jorge J. Castillo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Age-time risk patterns of solid cancers in 60 901 non-Hodgkin lymphoma survivors from Finland, Norway and Sweden
Justo Lorenzo Bermejo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Rituximab Extended Schedule or Re-Treatment Trial for Low-Tumor Burden Follicular Lymphoma: Eastern Cooperative Oncology Group Protocol E4402
Brad S. Kahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Survival of Patients With Marginal Zone Lymphoma Analysis of the Surveillance, Epidemiology, and End Results Database
Adam J. Olszewski et al.
CANCER (2013)
Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma An analysis of clinical presentation and outcome in 144 patients
Andreas Heilgeist et al.
CANCER (2013)
Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases
Carlos Montalban et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
MYD88 L265P Somatic Mutation in Waldenstrom's Macroglobulinemia
Steven P. Treon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Risk for second malignancies in non-Hodgkin's lymphoma survivors: a meta-analysis
M. Pirani et al.
ANNALS OF ONCOLOGY (2011)
2CdA chemotherapy and rituximab in the treatment of marginal zone lymphoma
Enrico Orciuolo et al.
LEUKEMIA RESEARCH (2010)
Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease
Luca Arcaini et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Clinical implications of nodal marginal zone B-cell lymphoma among Japanese: study of 65 cases
Masaru Kojima et al.
CANCER SCIENCE (2007)
The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma
Jonathan D. Tward et al.
CANCER (2006)
Follicular lymphoma international prognostic index
P Solal-Céligny et al.
BLOOD (2004)
Nodal marginal zone lymphoma:: A heterogeneous tumor -: A comprehensive analysis of a series of 27 cases
FI Camacho et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients
F Berger et al.
BLOOD (2000)
分享论文
